DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2023

Aug 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2023-08-07

Reporting Person: Burgess Justin (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-07	Common Stock	M	2528	$5.42	Acquired	2528	Direct
2023-08-07	Common Stock	M	5533	$9.41	Acquired	8061	Direct
2023-08-07	Common Stock	S	8061	$14.545	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-07	Stock Option (Right to Buy)	$5.42	M	2528	Disposed	2027-02-11	Common Stock (2528)	Direct
2023-08-07	Stock Option (Right to Buy)	$9.41	M	5533	Disposed	2028-02-02	Common Stock (5533)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $14.54 to $14.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.

F2: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 12. 2020, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F3: Not applicable.

F4: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.